These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
199 related items for PubMed ID: 3283685
1. [Influence of aminoglycosides on the activity of urinary N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzymes]. Mozer JL, Gibey R, Dupond JL, Henry JC. Pathol Biol (Paris); 1988 Mar; 36(3):230-4. PubMed ID: 3283685 [Abstract] [Full Text] [Related]
2. [An early and specific indicator of aminoglycoside nephrotoxicity: isoenzyme B of urinary N-acetyl-beta-D-glucosaminidase (NAG)]. Gibey R, Dupond JL, Peltier H, Iehl-Robert M, Henry JC. Pathol Biol (Paris); 1986 May; 34(5):342-5. PubMed ID: 3534703 [Abstract] [Full Text] [Related]
3. [Inhibition of the activity of urinary N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzymes by amikacin]. Mozer JL, Gibey R, Henry JC. C R Seances Soc Biol Fil; 1989 May; 183(2):166-73. PubMed ID: 2531024 [Abstract] [Full Text] [Related]
5. Comparative effects of gentamicin, amikacin and dactimicin on excretion of N-acetyl-beta-D-glucosaminidase (NAG) and kidney histological pattern in rats. Palla R, Paternoster G, Galigani P, Giovannini L, Bertelli AA, Romano MR, Alessandrì MG, Bertelli A. Drugs Exp Clin Res; 1987 May; 13(12):751-6. PubMed ID: 3447879 [Abstract] [Full Text] [Related]
6. [Isoenzymes of N-acetyl-beta-D-glucosaminidase (NAG): new method of evaluating the nephrotoxicity of aminosides. Our experience with dibekacin in geriatrics]. Gibey R, Dupond JL, Mallet H, Guerber F, Iehl-Robert M, Flausse-Parrot F, Becker M. Nephrologie; 1986 May; 7(2):51-5. PubMed ID: 3736764 [Abstract] [Full Text] [Related]
9. [Nephrotoxicity of aminoglycosides and cephalosporins. Value of examining the isoenzyme profile of N-acetyl-beta-D-glucosaminidase]. Dupond JL, Gibey R, Iehl-Robert M, Mallet H, Leconte des Floris R, Henry JC. Rev Med Interne; 1984 Nov; 5(4):321-7. PubMed ID: 6522881 [Abstract] [Full Text] [Related]
11. Urinary N-acetyl-beta-D-glucosaminidase (NAG) isoenzyme profiles: a tool for evaluating nephrotoxicity of aminoglycosides and cephalosporins. Gibey R, Dupond JL, Henry JC. Clin Chim Acta; 1984 Feb 14; 137(1):1-11. PubMed ID: 6697524 [Abstract] [Full Text] [Related]
12. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 10. Clinical significance of urinary NAG activity in patients with kidney diseases, with special reference to nephrotic syndrome and antibiotic treatment]. Ishimoto F, Shibazaki T, Murai S, Kodama K, Ohno I, Gomi H. Rinsho Byori; 1983 Sep 14; Spec No 56():147-59. PubMed ID: 6663756 [No Abstract] [Full Text] [Related]
13. The role of NAG (N-acetyl-beta-D-glucosaminidase) in the diagnosis of kidney disease including the monitoring of nephrotoxicity. Price RG. Clin Nephrol; 1992 Sep 14; 38 Suppl 1():S14-9. PubMed ID: 1295704 [Abstract] [Full Text] [Related]
15. [Urinary N-acetyl-beta-D-glucosaminidase and its isoenzymes in smoking and non-smoking workers at copper foundry occupational co-exposed to arsenic cadmium and lead]. Milnerowicz H, Bizoń A, Witt K, Antonowicz-Juchniewicz J, Andrzejak R. Przegl Lek; 2008 Sep 14; 65(10):518-21. PubMed ID: 19189537 [Abstract] [Full Text] [Related]